Cancer Vaccines Market Future Trends and Scope Analysis by 2024

About This Presentation

Title:

Cancer Vaccines Market Future Trends and Scope Analysis by 2024

Description:

Infinium Global Research has added a new report on Global Cancer Vaccines Market. The report predicts the market size of Cancer Vaccines is expected to reach XX billion by 2024. – PowerPoint PPT presentation

Number of Views:77

Slides: 8

Provided by: bondallen78

Category: Other

Tags: cancer_vaccines_market_data | cancer_vaccines_market_report | cancer_vaccines_market_research | cancer_vaccines_market_size | cancer_vaccines_market

more less

Transcript and Presenter's Notes

Title: Cancer Vaccines Market Future Trends and Scope Analysis by 2024

1
Cancer Vaccines Market Global Industry Analysis,
Trends, Market Size and Forecasts up to 2024
2
A recent report published by Infinium Global
Research on cancer vaccines market provides in
depth analysis of segments and sub-segments in
global as well as regional markets of cancer
vaccines market. Cancer vaccine either treats
cancer or prevents development of cancer.
Vaccines that treat existing cancer are known as
therapeutic cancer vaccines. Cancer vaccine uses
weakened or killed germs such as viruses or
bacteria to start an immune response in the body.
With the help of these viruses the immune system
gets stronger to fight against the infections.
Some traditional vaccines such as human papilloma
virus and hepatitis B virus help prevent victims
from cancers. These types of vaccines are useful
for the cancer caused through infections. A
number of common etiologic factors have been
strongly characterized as raising the risk of
developing cancer including age, chronic
inflammation, gender, obesity, tobacco usage
and heritable cancer syndromes. There are
two types of cancer vaccines namely
prevention vaccines and treatment vaccines.
Prevention vaccines are given to healthy
people to keep certain cancers from
developing like viruses for chickenpox and flu
they protect the body that can cause disease.
Cancer treatment vaccines are the type of
vaccines that work to boost the bodys immune
system to fight against cancer. Doctors give
treatment vaccines to prevent the cancer from
reoccurring, destroy the cancer cells after the
treatment has been taken and as well stop a
tumour from growing and coming back. The cancer
treatment vaccine works as there are some
substances on the surface of the cells called as
Antigens. These Antigens are never the part of
human body and hence they attack the immune
system and this immune system helps to respond
against those Antigens in the future. Cancer
treatment vaccines boost the immune systems
ability to recognise and destroy antigens. Some
cancer vaccines are made for each patient they
are produced from the patients tumour sample
which indicates that surgery is needed to get
large amount of tumour sample to create vaccines.
According to report the global cancer vaccines
market is projected to grow at a CAGR of 17.8
over the forecast period of 2018 - 2024. Market
insights According to Cancer Research UK in 2012,
around 14.1 million new cancer cases occurred
worldwide. The frequency rate of cancer is
increasing due to unhealthy lifestyle, hereditary
issues and environmental changes. This huge
disease burden will drive the market in the
forecast period. The global market is driven by
rise in occurrence of HPV infections and related
cancer, increase in administration of
prophylactic cancer vaccines, surge in
investments findings in the development of
cancer vaccines, and launch of novel cancer
vaccines in the market. The UNICEF and WHO have
published guidelines on developing a national
immunization plan, the comprehensive Multi-Year
Plan (cMYP) for all nations across the globe,
which expects to ensure fair access to
vaccination facilities for all individuals. As
compared to the cancer pharmaceutical market the
cancer vaccine market is considered relatively
smaller and it is the restraining factor for the
growth of cancer vaccine market currently.
Moreover, the strict supervisory factor related
to pre and post marketing approvals is another
factor hampering the growth of the market. Due to
the increase in demand for preventive cancer
vaccines thepaediatric vaccines segment is
expected to exhibit high growth rate during
forecast period thereby providing high growth
opportunities for the major players in cancer
vaccine market.
3

Segments Covered
The report covers the analysis of global as well
as regional markets of cancer vaccine market.
Moreover, the cancer vaccine market is segmented
on the basis of by technology, by type, by
indication and by end-user. Based on the
technology the cancer vaccine market has been
segmented into Whole Cell Cancer Vaccine,
Dendritic Cells Cancer Vaccines
Antigen/Adjuvant Cancer Vaccines, Recombinant
Cancer Vaccines and Viral
Vector DNA Cancer Vaccines. Moreover the types
covered in the study include Preventive Cancer
Vaccines and Therapeutic Cancer Vaccines. Based
on the indication the market has been segmented
into Prostate Cancer Cervical Cancer and Others.
Similarly, according to end-use the market is
segmented into Adult Vaccines and Pediatric
Vaccine.
Geographies covered
The global Cancer vaccine market covers the
analysis of geographies such as North America,
Europe, Asia-Pacific and RoW. In this section,
the key
trends and market size for each region is
provided over the period of 20182024. Among
geographies North America is the most developed
region, and is expected to generate highest
estimated revenue by 2024.Asia-Pacific witnessed
the highest growth rate for cancer vaccines over
2016 to 2017, and is expected to grow throughout
the forecast period.
Get Free Sample Pages of this Report
https//www.infiniumglobalresearch.com/Reports/Mak
eSampleRequest/1096 Table of Contents-
Preface
Report Description
Research Methods
Research Approaches